| J9271 | Injection, pembrolizumab, 1 mg | 15,600 | $40 | $670.8K |
| J0897 | Injection, denosumab, 1 mg | 10,260 | $20 | $194.9K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 880 | $120 | $108.4K |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 520 | $80 | $41.3K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 350 | $120 | $41K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 130 | $180 | $23.3K |
| J1454 | Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 60 | $340 | $20.2K |
| 99205 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider… | 70 | $220 | $15.4K |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 110 | $130 | $14.9K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 170 | $80 | $13.9K |